![Raj Mehra](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Raj Mehra is the founder of Seelos Therapeutics, Inc., where he currently holds the position of President & Chief Executive Officer since 2024.
He founded the company in 1987.
Dr. Mehra is also the founder of Weiss, Peck & Greer LLC.
Dr. Mehra's former job positions include Chairman, President, Chief Executive Officer & CFO at Apricus Biosciences, Inc., Chairman, Chief Executive Officer & Secretary at Seelos Therapeutics, Inc., Managing Director at Auriga USA LLC, Director at Larkspur Health Acquisition Corp., and Head-Healthcare Equity Investments at Bennett Lawrence Management LLC.
In terms of education, Dr. Mehra holds a graduate degree, an MBA, and a doctorate from The Trustees of Columbia University in The City of New York.
He also holds an undergraduate degree from the Indian Institute of Technology Kanpur.
| Sociétés | Poste | Début |
|---|---|---|
| SEELOS THERAPEUTICS, INC. | Directeur Général | 01/01/2019 |
| Sociétés | Poste | Fin |
|---|---|---|
| LARR HEALPAR | Directeur/Membre du Conseil | 01/12/2022 |
Weiss, Peck & Greer LLC
 Weiss, Peck & Greer LLC Investment Banks/BrokersFinance Security Brokers Dealers And Flotation Companies | Fondateur | - |
Bennett Lawrence Management LLC
 Bennett Lawrence Management LLC Investment ManagersFinance Bennett Lawrence Management (BLM) conducts in-house primary research to identify unique, high growth investment opportunities. Their strategies include: the Bennett Lawrence Growth Equity Composite, the Bennett Lawrence Mid-Cap Composite, The Bennett Lawrence Growth Equity Composite is an all-cap growth strategy. The composite contains the performance results of all fully discretionary portfolios in this strategy. The market-caps of these portfolios fluctuate depending upon market conditions. BLM's growth equity portfolios are suitable for investors seeking long-term capital appreciation. Investments are made in competitively advantaged companies that serve high growth markets. Portfolios are privately managed and tax considerations, social/religious concerns and other client issues may be included in the process. The Bennett Lawrence Mid-Cap Composite is a mid-cap growth strategy. The composite contains the performance results of all fully discretionary portfolios. 80% of the portfolio's equity market value is typically invested in the stocks of companies with a market-cap of $15 billion or less at cost. In general, the weighted average market-cap of the portfolio will be no more than 1.5 times the weighted average capitalization of the Russell Midcap Growth Index. Investments are made in competitively advantaged companies that serve high growth markets. Portfolios are privately managed and tax considerations, social/religious concerns and other client issues may be included in the process. The Bennett Lawrence Small-Cap Composite is a small-cap growth strategy. The composite contains the performance results of all fully discretionary portfolios. In general, 75% of BLM's small-cap portfolios' holdings will be in the shares of companies with a market-cap of $2.5 billion or less at the time of initial purchase. Portfolios seek to provide long-term growth investors a way to access growth opportunities in the shares of smaller companies. Portfolios are privately managed and tax considerations, social/religious concerns and other client issues may be included in the process. BLM's long/short seeks to amplify the core concepts of their growth investment approach through the use of leverage and short positions. The firm seeks to capitalize on the lack of Wall Street research coverage among smaller and mid-sized companies. They select long positions that can capitalize on the long-term earnings growth potential of competitively advantaged companies that are benefiting from strong demand trends. BLM's short positions focus on the shares of companies that have deteriorating growth prospects. The firm manages market risk through the use of both company specific short positions short sales of ETFs. | Corporate Officer/Principal | - |
Auriga USA LLC
 Auriga USA LLC Investment Banks/BrokersFinance Provides brokerage services | Directeur Général | - |
Apricus Biosciences, Inc.
 Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Designs, develops and commercialises therapeutic products | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 9 |
|---|---|
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Designs, develops and commercialises therapeutic products | Health Technology |
Bennett Lawrence Management LLC
Bennett Lawrence Management LLC Investment ManagersFinance Bennett Lawrence Management (BLM) conducts in-house primary research to identify unique, high growth investment opportunities. Their strategies include: the Bennett Lawrence Growth Equity Composite, the Bennett Lawrence Mid-Cap Composite, The Bennett Lawrence Growth Equity Composite is an all-cap growth strategy. The composite contains the performance results of all fully discretionary portfolios in this strategy. The market-caps of these portfolios fluctuate depending upon market conditions. BLM's growth equity portfolios are suitable for investors seeking long-term capital appreciation. Investments are made in competitively advantaged companies that serve high growth markets. Portfolios are privately managed and tax considerations, social/religious concerns and other client issues may be included in the process. The Bennett Lawrence Mid-Cap Composite is a mid-cap growth strategy. The composite contains the performance results of all fully discretionary portfolios. 80% of the portfolio's equity market value is typically invested in the stocks of companies with a market-cap of $15 billion or less at cost. In general, the weighted average market-cap of the portfolio will be no more than 1.5 times the weighted average capitalization of the Russell Midcap Growth Index. Investments are made in competitively advantaged companies that serve high growth markets. Portfolios are privately managed and tax considerations, social/religious concerns and other client issues may be included in the process. The Bennett Lawrence Small-Cap Composite is a small-cap growth strategy. The composite contains the performance results of all fully discretionary portfolios. In general, 75% of BLM's small-cap portfolios' holdings will be in the shares of companies with a market-cap of $2.5 billion or less at the time of initial purchase. Portfolios seek to provide long-term growth investors a way to access growth opportunities in the shares of smaller companies. Portfolios are privately managed and tax considerations, social/religious concerns and other client issues may be included in the process. BLM's long/short seeks to amplify the core concepts of their growth investment approach through the use of leverage and short positions. The firm seeks to capitalize on the lack of Wall Street research coverage among smaller and mid-sized companies. They select long positions that can capitalize on the long-term earnings growth potential of competitively advantaged companies that are benefiting from strong demand trends. BLM's short positions focus on the shares of companies that have deteriorating growth prospects. The firm manages market risk through the use of both company specific short positions short sales of ETFs. | Finance |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indian Institute of Technology Kanpur
 Indian Institute of Technology Kanpur Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weiss, Peck & Greer LLC
Weiss, Peck & Greer LLC Investment Banks/BrokersFinance Security Brokers Dealers And Flotation Companies | Finance |
Auriga USA LLC
Auriga USA LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Seelos Therapeutics, Inc. /Old/
 Seelos Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Develops novel therapeutics | Health Technology |
Seelos Therapeutics, Inc.
 Seelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for neurological disorders and rare diseases using pipeline targeting CNS conditions | Health Technology |
Larkspur Health Acquisition Corp.
 Larkspur Health Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
